Novartis posts daNIS-3 phase 2 results; registers Phase 3 PINNACLE-MI cardiac trialNov 16Weekly roundup, 4 itemsNovartis
Novartis registers two Phase I trials: TRB191 in SCLC and XEP527 in schizophreniaNov 6Weekly roundup, 10 itemsArdtartemether and lumefantrine
Novartis posts Cosentyx nail psoriasis and imatinib results; Piqray label updatedOct 30Weekly roundup, 8 itemsalpelisibeverolimusUpdated
Novartis terminates Phase 2 iptacopan lupus nephritis trial after Part 1Oct 15Trial updateiptacopanNovartis
Novartis registers new Phase 2 NIO752 tauopathy trial; Egaten results, six studies updateOct 9Weekly roundup, 8 itemsinclisiraniptacopanUpdated
Novartis registers new Phase IIIb IgAN trial and VEXAS Phase 2; gMG trial still activeOct 2Weekly roundup, 10 itemsarumakimigatrasentanUpdated
FDA approves new efficacy supplement for Novartis's FabhaltaJul 16Regulatory decisioniptacopanNovartis